Frontiers | IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
WHO standards for COVID-19 established by the ECBS in Dec 2020
Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines | npj Vaccines
Clinical Chemistry and Laboratory Medicine (CCLM)
Frontiers | Harmonization of Multiple SARS-CoV-2 Reference Materials Using the WHO IS (NIBSC 20/136): Results and Implications
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Anti-Spike protein assays to determine post-vaccination antibody levels: a head-to-head comparison of five quantitative assays | medRxiv
Vaccines | Free Full-Text | Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine
RapiReadTM CUBE Reader - Bioforniture
Comprehensive analysis of SARS-CoV-2 immune responses | Omnia Health Insights
U/ml to AU/ml conversion (COVID) : r/askmath
Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?
Anti-Spike protein assays to determine post-vaccination antibody levels: a head-to-head comparison of five quantitative assays | medRxiv
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection | Nature Medicine
Anti-Spike protein assays to determine post-vaccination antibody levels: a head-to-head comparison of five quantitative assays | medRxiv
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Towards a population-based threshold of protection for COVID-19 vaccines - ScienceDirect
Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination | npj Vaccines
Viruses | Free Full-Text | Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)
The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study | medRxiv
COVID-19 NAb Test Rapido Quantitativo per il dosaggio degli Anticorpi Neutralizzanti - Bioforniture
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection - eBioMedicine
Dr. Brown's WR206INTLX - Kit conversione Biberon Options+ Ba 270 ml : Amazon.it: Prima infanzia
Evolution of SARS-CoV-2 spike antibodies (U/mL) in seronegative (blue)... | Download Scientific Diagram
